XML 39 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2024
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Common Stock
The Company is authorized to issue up to 150.0 million shares of voting common stock and 3.0 million shares of class B
non-voting common stock. 
The Company’s Board of Directors authorized share repurchase programs in October 2022, October 2023, and July 2024 to
repurchase up to 3.0 million, 3.3 million, and 5.4 million shares of its common stock, respectively, and these authorizations
have no expiry.  Purchases may be made from time to time, at management’s discretion, in the open market or in privately
negotiated transactions, including through the use of trading plans, as well as pursuant to accelerated share repurchase programs
or other share repurchase strategies that may include derivative financial instruments.  As of March 31, 2024, the Company had
repurchased all of the shares in the repurchase program authorized in October 2022.  As of December 31, 2024, the Company
had repurchased all of the shares in the repurchase program authorized in October 2023 and there were a total of 5.3 million
shares available for repurchase under the Company’s July 2024 share repurchase program.
The following is a summary of the Company’s share repurchase activity:
Shares
Repurchased
Average Price
Per Share
2022 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.5
$144.45
2023 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3.0
132.99
2024 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4.3
162.65
Equity Distribution Program
In the second quarter of 2022, the Company entered into equity distribution and forward equity agreements with several
major securities firms under which it may, from time to time, issue and sell shares of its common stock (immediately or on a
forward basis) having an aggregate sales price of up to $500.0 million (the “equity distribution program”).  As of December 31,
2024, no sales had occurred under the equity distribution program.
Preferred Stock
The Company is authorized to issue up to 5.0 million shares of preferred stock.  Any such preferred stock issued by the
Company may rank prior to common stock as to dividend rights, liquidation preference or both, may have full or limited voting
rights, and may be convertible into shares of common stock.
Financial Instruments
The Company’s junior convertible securities contain an embedded right for holders to receive shares of the Company’s
common stock under certain conditions.  These arrangements, as well as the equity distribution program, meet the definition of
equity and are not required to be accounted for separately as derivative financial instruments.